# The initiative seeks to bring U.S. drug costs in line with other wealthy countries.

*biotech · news · 2025-12-19 · Devdiscourse*

## Key points

- President Trump secured agreements with nine major drug companies to cut Medicaid and cash payer prices.
- Merck, Novartis, and GSK will reduce prices for a broad list of drugs under the deal.
- The agreements include significant discounts on medicines like Merck's Januvia and possible future drugs.
- The deals require increased U.S. manufacturing investment and faster FDA approvals for participating companies.

**Companies:** Bristol Myers Squibb, Gilead Sciences, Merck, Novartis, GSK
**Countries:** United States

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/business/3736656-trump-secures-big-pharma-deals-lower-drug-prices-for-medicaid-and-consumers)

---

Canonical: https://newsio.io/n/2e1f9902-4b1e-41df-9431-023504d2e599/the-initiative-seeks-to-bring-u-s-drug-costs-in-line-with-other-wealthy-countrie
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works